Skip to main content

Featured

The Rate Cuts Are Over — Is a Hike Coming?

  July 23, 2026 Oil shocks, sticky inflation and a technical recession are pulling the Bank of Canada in opposite directions at once. For most of the past two years, the only question about the Bank of Canada was how far and how fast it would cut. The overnight rate fell from 5.00% to 2.25% between June 2024 and October 2025, one of the sharpest easing cycles in the Bank's history, and it has held there through six consecutive decisions since. That story is now over. The question on the table for the rest of 2026 isn't whether the Bank cuts again — it's whether the next move is actually a hike. Two conflicting signals, one Bank The case for staying put — or even cutting — comes from the growth side of the ledger. Statistics Canada data showed the economy contracted in both the fourth quarter of 2025 and the first quarter of 2026, meeting the informal definition of a technical recession. That was enough to have some economists warning the Bank had no room to raise rates at a...

article

Stock Market Today: Dow, S&P 500, Nasdaq Rebound Amid China Tariff Retaliation and New Jobs Data

                                    

US stocks rebounded on Tuesday as investors assessed China's swift retaliation to the latest US tariffs and digested fresh jobs data. The Dow Jones Industrial Average rose by 0.2%, while the S&P 500 gained 0.7%, and the tech-heavy Nasdaq Composite jumped 1.2%.

China responded to the new 10% tariffs imposed by the US with tariffs of its own on US coal, liquified natural gas, crude oil, farm equipment, and some autos. Despite the escalating trade tensions, some analysts see China's measured response as a potential opening for compromise.

Meanwhile, job openings in the US declined more than expected in December, adding to concerns about the labor market's cooling trend. Investors are closely watching these developments as the Federal Reserve considers future interest rate cuts amid ongoing inflation concerns.

Tech stocks led the gains, with Alphabet (Google) shares rising nearly 2% ahead of its fourth-quarter earnings report. Vaccine stocks, however, fell after Robert F. Kennedy Jr.'s nomination to lead the Health and Human Services Department advanced to the Senate.

Overall, the market's positive reaction suggests cautious optimism as traders navigate the complexities of trade relations and economic data.



Comments